Established in 2005, Qingdao Vland Biotech, previously known as KDN Biotech Group, is now a leader in biotech dedicated to the R&D, manufacture and marketing of enzymes, probiotics, animal vaccines and animal health care products. With more than 35 subsidiaries, Vland has enjoyed rapid and sustainable development through its strong capability in R&D, especially in molecular biology and protein modification. Together with world renowned research institutes and business partners, we have established optimum product application research systems for safety and efficacy evaluation, as well as a large database for producing optimum complex enzyme and probiotics formulation that best meet the ever-changing needs of the global market.